Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected Indications research hub

A Phase I/II, First-In-Human, Multi-Part, Open-Label, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF1001 in Patients With Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected Indications

This study is testing a new treatment, DF1001, for advanced or spreading cancers. It will look at how safe the treatment is, what side effects it causes, and how it affects the body. Researchers also want to see if it can help shrink tumours or stop them from growing.